Cherry SE Financial Update: Key Developments
Cherry SE, a German company based in Munich, specializes in manufacturing consumer electronic devices, including keyboards, mice, and other computer accessories. The company operates within the Information Technology sector and is listed on the Xetra exchange. As of August 11, 2025, Cherry SE’s stock closed at 0.74 EUR, with a market capitalization of 19,440,000 EUR. The company’s 52-week high was 2.345 EUR on August 18, 2024, and its 52-week low was 0.5 EUR on October 8, 2024. The price-to-earnings ratio stands at -0.364.
Rescheduling of Half-Year Report
On August 13, 2025, Cherry SE announced the rescheduling of its 2025 half-year report. Initially set for release on August 14, the report’s publication has been postponed to September 26, 2025. This decision was communicated through multiple sources, including eqs-cockpit.com, finanzen.net, and eqs-news.com. The delay is attributed to pending clarifications regarding down payments, as stated in the announcements.
Preliminary Announcement of Financial Reports
In a related development, Cherry SE issued a preliminary announcement regarding the publication of financial reports in compliance with Articles 114, 115, and 117 of the German Securities Act (WpHG). This announcement, also dated August 13, 2025, was disseminated through finanzen.net and eqs-cockpit.com, emphasizing the company’s commitment to regulatory transparency.
CHERRY Digital Health’s Regulatory Milestone
Earlier, on August 12, 2025, Cherry SE’s CHERRY Digital Health division received provider approval for its TI Messenger. This approval, highlighted in announcements from eqs-cockpit.com and eqs-news.com, signifies a GDPR-compliant and gematik-approved solution for the healthcare sector. The TI Messenger facilitates communication among healthcare stakeholders, with future plans to incorporate video features and AI-driven functionalities.
These developments reflect Cherry SE’s ongoing efforts to navigate regulatory requirements and expand its technological offerings in the healthcare domain.